STOCK TITAN

Biodelivery Sciences International - BDSI STOCK NEWS

Welcome to our dedicated news page for Biodelivery Sciences International (Ticker: BDSI), a resource for investors and traders seeking the latest updates and insights on Biodelivery Sciences International.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Biodelivery Sciences International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Biodelivery Sciences International's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52.75%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.82%
Tags
none
Biodelivery Sciences International

Nasdaq:BDSI

BDSI Rankings

BDSI Stock Data

577.05M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Raleigh

About BDSI

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.